Dec 13 (Reuters) - XBiotech Inc (XBIT):
* FDA APPROVES XBIOTECH'S IND IN RHEUMATOLOGY
* XBIOTECH INC (XBIT) - FDA'S DIVISION OF RHEUMATOLOGY HAS AUTHORIZED CO TO COMMENCE CLINICAL DEVELOPMENT OF NATRUNIX Source text for Eikon: Further company coverage: